Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...
"Regulatory flexibility must be tailored for cell and gene therapies," commented FDA Commissioner Marty Makary. "These are ...
In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory ...
Benefits seen from embracing platform technologies, combined with the role such systems played during the pandemic, are key dynamics.
WuXi Biologics introduces industry-leading digital twin platform PatroLab designed to transform bioprocessing and manufacturing: Shanghai Wednesday, January 14, 2026, 10:00 Hrs [I ...
For the last two years, the cultivated meat industry has been experiencing growing pains. Many startups have shrunk, shut ...
As cultivated meat companies push beyond proof-of-concept and toward commercialization, some of the sector’s most stubborn ...
Leadgene Biosolutions today announces the expansion of its product portfolio following its strategic integration into Leadgene Biomedical. The expanded portfolio supports both early-stage cell line ...
WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of PatroLabTM, a state-of-the-art digital twin platform ...
See our top 10 most-read science, research and technology stories from this year, featuring ‘Nobel Prize-worthy’ theabrownin, ...
The Tufts University Center for Cellular Agriculture (TUCCA), which seeks to enable production of meat, milk, and eggs from ...
Inside the race to turn one of cell biology’s least understood processes into a new foundation for drug development and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback